RecruitingNot ApplicableNCT06253000

Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium

Comparative Analysis of Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium in Patients With Persistent Atrial Fibrillation


Sponsor

Bakulev Scientific Center of Cardiovascular Surgery

Enrollment

158 participants

Start Date

Jun 10, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Atrial fibrillation (AF) is the cause of 20% of strokes, and the risk of stroke in a person suffering from this arrhythmia increases by 5 times. Ischemic stroke in patients with AF is often fatal and, compared with stroke of other etiology, leads to the most pronounced disability and more often recurs. Accordingly, the risk of death in patients with AF-related stroke is 2 times higher, and treatment costs increase 1.5 times. The main interventional method of treating AF, available in most medical institutions, is the use of radio frequency and/or cryoenergy to eliminate destructive damage to the left atrium (LA). The aim of this study is to compare two different interventional methods and identify predictors of recurrence in patients with persistent and long-term AF.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study compares two procedures — radiofrequency ablation and cryoablation — for treating a specific area of the heart (the posterior wall) in patients with persistent atrial fibrillation (an irregular heart rhythm that hasn't responded to medications). Both procedures use different forms of energy to scar heart tissue and stop irregular electrical signals. **You may be eligible if...** - You are between 18 and 80 years old - You have persistent or long-standing persistent atrial fibrillation that has not responded to antiarrhythmic medications - You have consented to participate **You may NOT be eligible if...** - You have another heart condition requiring surgery - You have had previous open-heart surgery - You have blood clotting disorders or bone marrow disease - Your heart pumping function is below 40% - You have poorly controlled blood pressure or kidney problems - Your mitral valve has significant damage - You are unlikely to return for follow-up visits Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURECryoablation

Cryoablation of the mouths of the pulmonary veins and the posterior wall of the left atrium.

PROCEDURERadiofrequency ablation

Radiofrequency ablation of pulmonary veins according to the "box isolation" type using a non-fluoroscopic navigation system.


Locations(1)

Bakulev National Medical Research Center for Cardiovascular Surgery

Moscow, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06253000


Related Trials